Breaking News, Collaborations & Alliances

QSV Gets Tissue Therapies Contract

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

QSV Biologics, Ltd. has signed a contract with biomedical company, Tissue Therapies, Ltd., for the process development and cGMP manufacture of clinical quantities of some of the therapeutic protein components of the VitroGro platform for the accelerated healing of burns. These are some of the essential components of the VitroGro, formulation that Tissue Therapies will use in a clinical trial later this year. Tissue Therapies is an Australian company developing biomedical technologies for wound h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters